Sehat Sahulat Thalassemia Transfusion at Chughtai Lab

Sehat Sahulat Card Thalassemia Patient Transfusion at Chughtai Lab

Thalassemia is a chronic, inherited genetic blood disorder characterized by a significant reduction in the synthesis of hemoglobin chains, leading to microcytic hypochromic anemia, ineffective erythropoiesis, and accelerated red blood cell destruction. For individuals diagnosed with Thalassemia Major or severe Thalassemia Intermedia, lifelong, regular blood transfusions are the cornerstone of survival and clinical management. Recognizing the immense physical, emotional, and financial burden this condition places on families, Chughtai Lab, a premier diagnostic and healthcare network in Pakistan, offers specialized blood transfusion services under the government’s Sehat Sahulat Program. Through the Sehat Sahulat Card Thalassemia Patient Transfusion service at Chughtai Lab’s dedicated Patient Care Units (Pt. Care Units), eligible patients can access safe, screened, and highly regulated blood transfusions completely free of cost.

This initiative combines Chughtai Lab’s state-of-the-art hematology expertise, advanced blood banking technology, and compassionate patient care to deliver a seamless therapeutic experience. By utilizing the Sehat Sahulat Card, patients gain access to a safe clinical environment where every unit of blood undergoes rigorous screening for transfusion-transmitted infections (TTIs) using advanced nucleic acid testing (NAT) and chemiluminescence immunoassay (CLIA) technologies. This ensures the highest standards of safety, minimizing the risk of infections and transfusion-related complications. The dedicated Patient Care Units at Chughtai Lab are designed specifically to cater to the unique needs of thalassemia patients, providing a comfortable, sterile, and monitored environment staffed by experienced hematologists, transfusion specialists, and trained nursing professionals who specialize in pediatric and adult vascular access.

Clinical Procedure: What to Expect

Patient Preparation

• Documentation and Verification: Patients must bring their original Computerized National Identity Card (CNIC) or Child Registration Certificate (B-Form) along with their active Sehat Sahulat Card to the Chughtai Lab Patient Care Unit for eligibility verification.
• Medical Records and Referral: Carry all previous medical records, including diagnostic reports confirming Thalassemia, blood group reports, and a formal referral or prescription from a registered consultant hematologist or pediatrician.
• Pre-Transfusion Laboratory Testing: Prior to the transfusion, a fresh blood sample will be collected at Chughtai Lab for complete blood count (CBC), blood grouping (ABO and Rh typing), and cross-matching to ensure donor-recipient compatibility.
• Screening and Baseline Vitals: The clinical team will record baseline vital signs, including temperature, blood pressure, heart rate, and oxygen saturation, to establish a clinical baseline before the transfusion begins.
• Hydration and Nutrition: Patients are advised to consume a light meal and remain well-hydrated before arriving at the Patient Care Unit. Fasting is not required for a blood transfusion.
• Medication Review: Inform the clinical team of all current medications, especially iron chelators (such as deferasirox or deferoxamine) or any history of allergic reactions during previous transfusions.

During the Procedure

• Patient Positioning: The patient is comfortably positioned in a specialized transfusion chair or bed within the Chughtai Lab Patient Care Unit to ensure relaxation and ease of monitoring.
• Vascular Access: A highly skilled nurse will establish intravenous (IV) access, typically using a sterile, single-use cannula in a peripheral vein. For pediatric patients or those with difficult venous access, specialized techniques and pediatric needles are utilized.
• Double-Verification Protocol: Before initiating the transfusion, two qualified healthcare professionals will perform a strict bedside double-verification of the patient’s identity, Sehat Card details, blood bag unit number, blood group compatibility, and expiration date.
• Transfusion Initiation and Monitoring: The transfusion of packed red blood cells (PRBCs) is initiated slowly. The clinical team closely monitors the patient for the first 15 minutes—the most critical window for acute transfusion reactions—checking vitals frequently.
• Duration: The entire transfusion process typically takes between 2 to 4 hours per unit of blood, depending on the patient’s age, clinical status, and the volume prescribed by the physician.
• Continuous Surveillance: Throughout the procedure, trained medical staff remain present in the Patient Care Unit to monitor for any signs of adverse reactions, such as fever, chills, itching, hives, shortness of breath, or back pain.
• Post-Transfusion Care: Once the transfusion is complete, the IV line is flushed or removed, and the patient is monitored for an additional 15 to 30 minutes to ensure clinical stability before discharge.

When is a Sehat Sahulat Card Thalassemia Patient Transfusion Performed?

Severe Symptomatic Anemia in Beta-Thalassemia Major

Beta-Thalassemia Major is characterized by a severe deficiency in beta-globin chain synthesis, leading to ineffective erythropoiesis and profound anemia. Patients typically present within the first two years of life with severe pallor, irritability, poor feeding, and failure to thrive. Regular blood transfusions are initiated when the hemoglobin level drops below 7 g/dL on two separate occasions (excluding other causes like iron deficiency) or when symptomatic anemia impairs growth and development. The Sehat Sahulat Card program at Chughtai Lab ensures these critical, life-sustaining transfusions are accessible without financial barriers.

Prevention of Musculoskeletal and Bone Deformities

In inadequately transfused thalassemia patients, the body attempts to compensate for chronic anemia by dramatically expanding the bone marrow space (erythroid hyperplasia). This leads to characteristic skeletal deformities, such as frontal bossing, prominent cheekbones (thalassemic facies), and thinning of the cortex of long bones, increasing the risk of pathological fractures. Regular, well-regulated blood transfusions at Chughtai Lab’s Patient Care Units suppress endogenous erythropoiesis, thereby preventing these debilitating musculoskeletal complications and preserving normal bone structure.

Management of Splenomegaly and Hypersplenism

Chronic anemia and ineffective red blood cell production force the spleen to work excessively to filter abnormal red blood cells, leading to splenomegaly (enlarged spleen). Over time, an overactive spleen (hypersplenism) can accelerate the destruction of transfused red blood cells, increasing transfusion frequency requirements. Regular transfusions covered under the Sehat Sahulat Card help maintain stable hemoglobin levels, reducing the workload on the spleen, delaying or preventing the onset of hypersplenism, and potentially avoiding the need for surgical splenectomy.

Prevention of Growth Retardation and Endocrine Dysfunction

Chronic hypoxia resulting from severe anemia severely impairs physical growth, sexual maturation, and endocrine function in children with thalassemia. By maintaining a pre-transfusion hemoglobin level between 9.5 and 10.5 g/dL through scheduled transfusions at Chughtai Lab, tissues receive adequate oxygenation. This supports normal childhood growth trajectories, prevents delay in puberty, and reduces the risk of endocrine complications such as diabetes mellitus, hypothyroidism, and hypoparathyroidism.

Pre-operative Optimization and Cardiopulmonary Support

Thalassemia patients undergoing surgical procedures (such as splenectomy or cholecystectomy) require meticulous pre-operative optimization. Chronic anemia places a continuous high-output strain on the cardiovascular system, which can lead to cardiomegaly and heart failure. Administering a planned blood transfusion at Chughtai Lab’s specialized unit prior to surgery optimizes oxygen-carrying capacity, stabilizes cardiopulmonary function, and significantly reduces perioperative risks and complications.

What Does a Sehat Sahulat Card Thalassemia Patient Transfusion Detect or Monitor?

During the transfusion process and the associated laboratory workups at Chughtai Lab, several critical hematological, immunological, and physiological parameters are monitored to ensure patient safety and therapeutic efficacy:

• Pre-transfusion Hemoglobin (Hb) levels to assess the degree of anemia and determine transfusion volume.
• Post-transfusion Hemoglobin (Hb) levels to evaluate the therapeutic response and red cell survival.
• ABO and Rh blood group compatibility to prevent acute hemolytic transfusion reactions.
• Presence of Red Blood Cell Alloantibodies through advanced antibody screening.
• Serum Ferritin levels to monitor systemic iron overload resulting from chronic transfusions.
• Complete Blood Count (CBC) parameters, including hematocrit and red cell indices.
• Baseline and post-procedural body temperature to detect febrile non-hemolytic transfusion reactions (FNHTR).
• Blood pressure variations to monitor for transfusion-associated circulatory overload (TACO) or hypotension.
• Heart rate and rhythm to identify cardiovascular strain or acute allergic reactions.
• Oxygen saturation (SpO2) levels to ensure adequate tissue oxygenation and detect respiratory distress.
• Screening for Hepatitis B Surface Antigen (HBsAg) in donor blood to prevent viral transmission.
• Screening for Hepatitis C Virus (HCV) antibodies/RNA in donor blood to ensure viral safety.
• Screening for Human Immunodeficiency Virus (HIV-1/2) in donor blood.
• Screening for Syphilis (VDRL/RPR) in donor blood.
• Screening for Malaria parasites in donor blood.
• Serum bilirubin levels (total, direct, and indirect) to monitor for subclinical hemolysis.
• Serum lactate dehydrogenase (LDH) as an indicator of red blood cell destruction.
• Urine output and color to detect hemoglobinuria (indicative of acute intravascular hemolysis).
• Serum creatinine and blood urea nitrogen (BUN) to monitor renal function.
• Serum electrolytes (potassium, calcium) to detect transfusion-related hyperkalemia or hypocalcemia.
• Signs of allergic reactions, including urticaria (hives), pruritus (itching), or bronchospasm.
• Liver function tests (ALT, AST) to monitor for iron-induced hepatic injury or viral hepatitis.
• Cardiac function indicators in patients with severe iron overload.
• Transfusion volume accuracy to prevent volume overload.
• Venous access site integrity to prevent infiltration, phlebitis, or localized infection.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, pre-transfusion testing, including complete blood count (CBC), blood grouping, and cross-matching, is performed with high efficiency to minimize waiting times for thalassemia patients. Cross-match results and donor screening verifications are typically completed within 1 to 2 hours of sample collection. Chughtai Lab provides seamless digital access to all laboratory reports. Patients and caregivers can access reports online through the official Chughtai Lab website, the Chughtai Lab Mobile App, or via automated WhatsApp alerts. Additionally, physical copies of reports can be collected directly from the Patient Care Unit or any Chughtai Lab collection center across Pakistan. This rapid reporting system ensures that clinical decisions can be made promptly, enhancing patient safety and convenience.

Sehat Sahulat Card Thalassemia Patient Transfusion Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Pre-transfusion Hemoglobin (Hb)	9.5 to 10.5 g/dL (Target for Thalassemia)	< 9.0 g/dL (Severe anemia requiring urgent transfusion)
Serum Ferritin	< 1,000 ng/mL (Target in chelated patients)	> 1,500 ng/mL (Severe iron overload requiring aggressive chelation)
ABO/Rh Compatibility	Complete compatibility (No agglutination)	Incompatibility (Agglutination, high risk of acute hemolysis)
Antibody Screen	Negative for clinically significant alloantibodies	Positive (Presence of alloantibodies, requiring antigen-negative blood)
Post-transfusion Hb Rise	Increase of 1.0 to 1.5 g/dL per unit transfused	Inadequate rise (Suggests active hemolysis, bleeding, or hypersplenism)
Donor Blood Screening	Non-reactive for HIV, HBV, HCV, Syphilis, Malaria	Reactive (Unit discarded immediately; unsafe for transfusion)
Patient Vital Signs	Stable (BP, HR, Temp, SpO2 within normal limits)	Fever, tachycardia, hypertension/hypotension, bronchospasm (Transfusion reaction)
Serum Potassium	3.5 to 5.0 mEq/L	> 5.5 mEq/L (Hyperkalemia, especially with older stored blood)
Serum Bilirubin (Total)	0.2 to 1.2 mg/dL	Elevated (Hemolytic reaction or progressive liver dysfunction)
Urine Color	Clear, light yellow	Dark red or tea-colored (Hemoglobinuria due to acute intravascular hemolysis)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Sehat Sahulat Card Thalassemia Patient Transfusion?

• Dedicated Patient Care Units: Chughtai Lab features specialized Patient Care Units designed to provide a comfortable, sterile, and safe environment specifically for thalassemia patients.
• Seamless Sehat Sahulat Card Integration: Fully empaneled under the government’s Sehat Sahulat Program, offering completely free-of-cost transfusion services to eligible cardholders.
• State-of-the-Art Blood Banking: Equipped with advanced blood processing and storage technologies to ensure the highest quality of packed red blood cells.
• Rigorous Donor Screening: Every unit of blood undergoes comprehensive screening for transfusion-transmitted infections (TTIs) using highly sensitive CLIA and NAT methods.
• Expert Clinical Oversight: Transfusions are monitored by experienced hematologists, clinical pathologists, and specialized transfusion nurses.
• Advanced Cross-Matching Protocols: Utilizing automated gel card technology for precise blood grouping and cross-matching to minimize the risk of alloimmunization.
• Convenient Digital Report Access: Patients can easily retrieve pre- and post-transfusion reports via the Chughtai Lab mobile app, website, or WhatsApp.
• Nationwide Network: With a vast presence across Pakistan, Chughtai Lab provides accessible, high-quality diagnostic and therapeutic support close to patients’ homes.